1. Home
  2. CTRN vs ASMB Comparison

CTRN vs ASMB Comparison

Compare CTRN & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citi Trends Inc.

CTRN

Citi Trends Inc.

SELL

Current Price

$48.73

Market Cap

559.1M

ML Signal

SELL

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$20.11

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRN
ASMB
Founded
1946
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
559.1M
512.1M
IPO Year
2005
2010

Fundamental Metrics

Financial Performance
Metric
CTRN
ASMB
Price
$48.73
$20.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
★ $91.00
$52.00
AVG Volume (30 Days)
151.7K
★ 301.0K
Earning Date
12-01-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 112.14
91.78
EPS
★ 0.80
N/A
Revenue
★ $819,962,000.00
N/A
Revenue This Year
$10.94
N/A
Revenue Next Year
$8.69
N/A
P/E Ratio
$62.43
★ N/A
Revenue Growth
★ 8.88
N/A
52 Week Low
$34.43
$19.98
52 Week High
$77.91
$39.71

Technical Indicators

Market Signals
Indicator
CTRN
ASMB
Relative Strength Index (RSI) 36.67 26.60
Support Level $42.10 N/A
Resistance Level $53.05 $30.36
Average True Range (ATR) 2.20 0.99
MACD 0.52 -0.04
Stochastic Oscillator 31.94 8.54

Price Performance

Historical Comparison
CTRN
ASMB

About CTRN Citi Trends Inc.

Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: